In a new strategic partnership with Salus Optima, IFF are developing a data driven personalized nutrition, health and wellness platform targeting metabolic health
Posted:
1 in 4 adults worldwide are affected by metabolic health issues such as obesity, pre-diabetes, high cholesterol, and pre-hypertension. IFF announced its plans for accelerated entry into the personalized nutrition sector through a strategic partnership with Salus Optima, a British-based, digitally-enabled personalized nutrition, health and wellness company. Read more here.
Amid ongoing battles over alternate supplies of blockbuster weight loss drugs, Eli Lilly filed new lawsuits against four telehealth firms and their affiliates, but is using a new line of attack — the drugmaker accused two of the companies of…
Hypertension, or high blood pressure, is known to have a direct impact on heart attack and stroke risk — but a new study has revealed its surprising link to brain health.
In a large, randomized trial, researchers led by First Hospital…
Attendees
Sponsors and Exhibitors
AI In Healthcare: A Virtual Course
Contact us